Angelini Pharma

We have selected Veeva Vault CRM as the new platform for our Customer Engagement Ecosystem, opening a new chapter in our collaboration with Veeva Systems. This means more than a CRM upgrade for us. It is a cross-functional investment in how people, data and technology work together across our organization, helping us serve patients better by giving our teams a more integrated, intelligent, and AI-ready way to engage with healthcare professionals. Technology is only part of the journey. What matters most is how we use it together: to listen more closely, respond more effectively and create value for healthcare professionals and, ultimately, for the patients we care for. It is a meaningful step in building a stronger, more connected global healthcare company, and we look forward to what our teams will build with it. #AngeliniPharma #DigitalTransformation #LifeSciences

Come possiamo ripensare i processi produttivi, per rendere la sostenibilità parte dell’innovazione? È questo uno dei temi che porteremo al Il Salone della CSR e dell'innovazione sociale, in programma dal 6 all’8 ottobre all’Università Bocconi di Milano. Giovedì 8 ottobre, Roberto Scrivo, il nostro Chief External Affairs, Communication & Sustainability Officer, parteciperà al talk “Transizione energetica: innovazione, efficienza, risparmio”, portando la nostra esperienza con LIFE-GREENAPI, il progetto che sta esplorando un nuovo approccio alla produzione dei principi attivi farmaceutici. Sarà un momento di confronto importante, moderato da Emanuela Taverna, Copy Strategist di Humans&Data, per condividere esperienze concrete e riflettere su come trasformare la transizione energetica in innovazione, efficienza e risultati misurabili. 📍 Università Bocconi, Milano 📅 8 ottobre | 9.30–10.30 #AngeliniPharma #SaloneCSR

Forbes shines a light on the transformation journey that is reshaping Angelini and strengthening the international footprint of our Group. From more than a century of history rooted in Italy to an increasingly global presence, Angelini has evolved with a clear ambition: building capabilities, partnerships and businesses able to compete on a global scale, while staying true to our heritage. For Angelini Pharma, this has meant a strategic evolution of our portfolio and a growing commitment to Brain Health and Rare Diseases. A journey that reached a significant milestone with the acquisition of Catalyst Pharmaceuticals, Inc. and our expansion into the U.S. market. As the article highlights, this step is part of a broader transformation driven by strategic choices, long-term vision and the determination to build a stronger global healthcare company. We are proud to see this journey recognised by Forbes cover story published on August 20th and even prouder of what lies ahead. We look forward to continuing to write the next chapter of our story. #AngeliniPharma Link to the article https://lnkd.in/etgUpkRK

In un contesto in cui il settore healthcare è chiamato a rispondere a sfide sempre più complesse, crediamo che crescita, innovazione e visione industriale debbano procedere insieme. Nell'intervista pubblicata lunedì da L'Economia del Corriere della Sera, il nostro CEO Sergio Marullo di Condojanni racconta le principali tappe del percorso di trasformazione avviato negli ultimi anni, fino all’acquisizione di Catalyst Pharmaceuticals, Inc. e all'espansione nel mercato statunitense. La nostra visione è chiara: rafforzare il nostro ruolo globale nelle neuroscienze e nelle malattie rare, continuare a investire nella scienza, nell'innovazione e nelle competenze per ampliare l'accesso a soluzioni terapeutiche in aree ad alto bisogno medico, continuare a servire al meglio pazienti e Istituzioni sanitarie. #AngeliniPharma #MalattieRare

Today is #WorldBrainDay. And it’s also the day we come together for the #BrainHealthChallenge2026, an initiative we are proud to support as a partner for another year. In today’s livestream session, we will explore the scientific connection between dance and Brain Health with Dr. Moritz Kielkopf and take part in an interactive live brain activation session with Dr. Barbara Studer, PhD. We will also learn the moves of the #BrainHealthDance2026, and hear from the international team driving this global initiative. 📅 July 22 🕠 17:30–18:15 CEST 💻 Online, via Zoom (registration available here: https://lnkd.in/esSWp-Xk Brain Health Challenge #AngeliniPharma #BrainHealth

For Dr. Moritz Kielkopf, neurologist and initiator of the Brain Health Challenge, the question that started everything was as simple as this: How can we make Brain Health something everyone can actively engage with? The result is a global initiative that brings together science, movement and participation through one shared challenge. As a proud partner of the #BrainHealthChallenge2026, we're excited to support an initiative that makes Brain Health more accessible, engaging and inclusive. Watch Dr. Kielkopf explain the idea behind this year's challenge, then join us on July 22 for #WorldBrainDay. #AngeliniPharma #BrainHealth